Illumina Appoints Ankur Dhingra As Chief Financial Officer and Jakob Wedel As Chief Strategy and Corporate Development Officer
Illumina Appoints Ankur Dhingra As Chief Financial Officer and Jakob Wedel As Chief Strategy and Corporate Development Officer
04/09/24, 8:13 PM
Position
chief strategy and corporate development officer
chief financial officer
Illumina announces the appointment of Ankur Dhingra as Chief Financial Officer, with extensive experience in the life sciences tools, diagnostics, and pharmaceutical industries. Additionally, Jakob Wedel has been named Chief Strategy and Corporate Development Officer, bringing 25 years of strategy leadership roles with global consulting firms.
Company Info
Additional Info
Illumina is improving human health by unlocking the power of the genome. Our focus on innovation has established us as the global leader in DNA sequencing and array-based technologies, serving customers in the research, clinical and applied markets. Our products are used for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments. To learn more, visit www.illumina.com and connect with us on Twitter, Facebook, LinkedIn, Instagram, and YouTube.
Investors:Brian Blanchett858.291.6421 IR@illumina.com
Media:Dr. Karen Birmingham646.355.2111 pr@illumina.com